MAY 04, 2016 7:04 AM PDT

Breast Cancer: Is the Gene Suspect List Complete?

WRITTEN BY: Xuan Pham
Massive sequencing study reveals 93 genes whose mutations lead to breast cancerScientists say they’re now closer than ever to personalized treatment for breast cancer after identifying a comprehensive list of genetic mutations that lead to the disease. The details of this study were published in a double-feature in Nature and Nature Communications.
 
The study was done by sequencing breast tumor samples from 560 patients, 556 were women, and four were men. This is the largest ever sequencing effort for breast cancer mutations.
 
In the resulting DNA sequences, the researchers searched for variations in genes that cause healthy cells to turn cancerous. "All cancers are due to mutations that occur in all of us in the DNA of our cells during the course of our lifetimes," said Mike Stratton, director of the Wellcome Trust Sanger Institute. "Finding these mutations is crucial to understanding the causes of cancer and to developing improved therapies."
 
 

The team identified 93 genes, which, when mutated, lead to breast tumors. While this list contains some already known suspects, such as BRCA1 and BRCA2, five genes on the list are new. Furthermore, they identified 12 new mutational signatures arising in patient tumors. Even in BRCA1/2, the team found highly specific mutational signatures that unique to some patients and not seen in others.
 
"There are about 20,000 genes in the human genome. It turns out, now we have this complete view of breast cancer - there are 93 of those [genes] that if mutated will convert a normal breast cell into a breast cancer cell. That is an important piece of information,” said Professor Sir Mike Stratton, director of the Sanger Institute in Cambridge, and senior study author.
 
Barring new and rare mutations that arise spontaneously, the team boldly claimed that their list is definitive and conclusive. Whether the gene list is truly complete will only be revealed with extended sequencing on more samples. In the mean time, the team plans to give the list of 93 genes to “the universities, the pharmaceuticals, the biotech companies to start developing new drugs because those mutated genes and their proteins are targets for new therapeutics,” said Stratton.
 
"This study both gave us the first large-scale view of the rest of the genome, uncovering some new reasons why breast cancer arises, and gave us an unexpected way to characterize the types of mutations that happen in certain breast cancers," said Ewan Birney, study co-author.
 
The list of genes and their associated mutations could be used to predict breast cancer risks in patients, especially for the hereditary types. In addition, knowing the specific mutations in a patient could allow doctors to custom-tailor treatments for every patient. "In the future, we'd like to be able to profile individual cancer genomes so that we can identify the treatment most likely to be successful for a woman or man diagnosed with breast cancer. It is a step closer to personalized healthcare for cancer," said Serena Nik-Zainal, first study author from the Wellcome Trust Sanger Institute in the United Kingdom.
 
Additional sources: Wellcome Trust Sanger InstituteBBC, MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
MAR 24, 2021
Cancer
What toxic chemicals are lurking in your couch?
MAR 24, 2021
What toxic chemicals are lurking in your couch?
New research published in the journal Environment International suggests a weekend trip to the nearest furniture st ...
MAY 03, 2021
Cardiology
Task Force IDs 7 Costly Medical Procedures With No Benefit
MAY 03, 2021
Task Force IDs 7 Costly Medical Procedures With No Benefit
Researchers have identified a surprising number of health screens that are given to patients who may not need them. Thes ...
MAY 10, 2021
Cancer
Advancements in nanotech pave the way for improved chemotherapy
MAY 10, 2021
Advancements in nanotech pave the way for improved chemotherapy
New research from Massachusetts General Hospital (MGH) reports on a development in improving the effectiveness of c ...
MAY 19, 2021
Health & Medicine
Who Ages Better, Men or Women?
MAY 19, 2021
Who Ages Better, Men or Women?
The answer depends on what's considered more important – quantity or quality of years?  Previous studies ...
JUN 07, 2021
Health & Medicine
Higher Incidence of Breast Cancer in Polluted Urban Areas
JUN 07, 2021
Higher Incidence of Breast Cancer in Polluted Urban Areas
A Taiwanese study looked at the incidence of breast cancer in areas of Taiwan with varying levels of air pollutants. Air ...
JUN 06, 2021
Cancer
New drug reduces tumor size in lung cancer patients with KRAS gene mutation
JUN 06, 2021
New drug reduces tumor size in lung cancer patients with KRAS gene mutation
The most recent results from the CODEBREAK 100 phase 2 clinical trial support the use of the drug sotorasib to reduce tu ...
Loading Comments...